Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shaun Martin, Aleksandra M. Dudek-Peric, Abhishek D. Garg, Heleen Roose, Seyma Demirsoy, Sofie Van Eygen, Freya Mertens, Peter Vangheluwe, Hugo Vankelecom & Patrizia Agostinis. (2017) An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells. Autophagy 13:9, pages 1512-1527.
Read now
Read now
Articles from other publishers (34)
Giammarco Nebbioso, Robel Yosief, Vasilij Koshkin, Yumin Qiu, Chun Peng, Vadim Elisseev & Sergey N. Krylov. (2023) Automated identification and tracking of cells in Cytometry of Reaction Rate Constant (CRRC). PLOS ONE 18:7, pages e0282990.
Crossref
Crossref
Amani Yehya, Joe Youssef, Sana Hachem, Jana Ismael & Wassim Abou-Kheir. (2023) Tissue-specific cancer stem/progenitor cells: Therapeutic implications. World Journal of Stem Cells 15:5, pages 323-341.
Crossref
Crossref
Chunfeng Xie, Chunhua Liang, Rong Wang, Kefan Yi, Xu Zhou, Xiaoting Li, Yue Chen, Dengshun Miao, Caiyun Zhong & Jianyun Zhu. (2023) Resveratrol suppresses lung cancer by targeting cancer stem-like cells and regulating tumor microenvironment. The Journal of Nutritional Biochemistry 112, pages 109211.
Crossref
Crossref
Kaige Yang, Yufang Xie, Lele Xue, Fanping Li, Chenghua Luo, Weihua Liang, Haijun Zhang, Ya Li, Yilin Ren, Mengmeng Zhao, Weinan Wang, Jia Liu, Xihua Shen, Wenhu Zhou, Jing Fei, Weigang Chen, Wenyi Gu, Lianghai Wang, Feng Li & Jianming Hu. (2023) M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma. Journal of Translational Medicine 21:1.
Crossref
Crossref
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Seema Parte, Abhirup C. Are, Surinder K. Batra & Moorthy P. Ponnusamy. (2022) Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Molecular Cancer 21:1.
Crossref
Crossref
Dayanidhi Raman & Amit K. Tiwari. (2020)
Role of
eIF4A1
in triple‐negative breast cancer stem‐like
cell‐mediated
drug resistance
. Cancer Reports 5:12.
Crossref
Crossref
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, Vishal Kumar Gupta, Shiv Govind Rawat, Ajay Kumar & Chandramani Pathak. (2020) Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Reports 5:12.
Crossref
Crossref
Shuaijun Lu, Yang Li, Changling Zhu, Weihua Wang & Yuping Zhou. (2022) Managing Cancer Drug Resistance from the Perspective of Inflammation. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Wenjie Huang, Fang Wen, Peixing Gu, Jiatong Liu, Yun Xia, Ye Li, Jiayu Zhou, Siyuan Song, Shuai Ruan, Suping Gu, Xiaoxue Chen & Peng Shu. (2022) The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters. Chinese Medicine 17:1.
Crossref
Crossref
Yanyan Ma, Zhanchen Guo, Chuanwen Fan, Jingran Chen, Shuxin Xu & Zhen Liu. (2022) Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance. Analytical Chemistry 94:20, pages 7375-7382.
Crossref
Crossref
Saeedeh Keyvani-Ghamsari, Khatereh Khorsandi, Azhar Rasul & Muhammad Khatir Zaman. (2021) Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clinical Epigenetics 13:1.
Crossref
Crossref
Hina Qayoom, Nissar A Wani, Bader Alshehri & Manzoor A Mir. (2021) An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future Oncology 17:31, pages 4185-4206.
Crossref
Crossref
Mohamed El‐Mesery, Axel Seher, Mohamed El‐Shafey, Mohamed El‐Dosoky & Farid A Badria. (2020) Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin‐induced sub‐G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells. Biotechnology and Applied Biochemistry 68:4, pages 832-840.
Crossref
Crossref
Asieh Emami Nejad, Simin Najafgholian, Alireza Rostami, Alireza Sistani, Samaneh Shojaeifar, Mojgan Esparvarinha, Reza Nedaeinia, Shaghayegh Haghjooy Javanmard, Marjan Taherian, Mojtaba Ahmadlou, Rasoul Salehi, Bahman Sadeghi & Mostafa Manian. (2021) The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell International 21:1.
Crossref
Crossref
Wei Wang, Ze Liang, Pengfei Ma, Qi Zhao, Mengyuan Dai, Jie Zhu, Xu Han, Hong Xu, Qingyan Chang & Yuhong Zhen. (2021) Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance. Bioconjugate Chemistry 32:1, pages 73-81.
Crossref
Crossref
Tomasz Wróbel, Marcin Luty, Jessica Catapano, Elżbieta Karnas, Małgorzata Szczygieł, Katarzyna Piwowarczyk, Damian Ryszawy, Grażyna Drabik, Ewa Zuba-Surma, Maciej Siedlar, Zbigniew Madeja, Martyna Elas & Jarosław Czyż. (2020) CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations. Stem Cells 38:12, pages 1544-1556.
Crossref
Crossref
Chenglong Wang, Wencai Guan, Rong Chen, Yael Levi-Kalisman, Yichun Xu, Liwen Zhang, Min Zhou, Guoxiong Xu & Hongjing Dou. (2020) Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential. Nano Research 13:11, pages 3110-3122.
Crossref
Crossref
Alessandro Dalpiaz, Guglielmo Paganetto, Giada Botti & Barbara Pavan. (2020) Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?. Drug Discovery Today 25:9, pages 1651-1667.
Crossref
Crossref
Preeyaporn Songkiatisak, Feng Ding, Pavan Kumar Cherukuri & Xiao-Hong Nancy Xu. (2020)
Size-dependent inhibitory effects of antibiotic nanocarriers on filamentation of
E. coli
. Nanoscale Advances 2:5, pages 2135-2145.
Crossref
Crossref
Jianxi Wang, Ning Li, Lei Cao, Chao Gao, Yan Zhang, Qizhi Shuai, Jinghui Xie, Kui Luo, Jun Yang & Zhongwei Gu. (2020) DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells. Journal of Materials Chemistry B 8:6, pages 1157-1170.
Crossref
Crossref
Stefania Nobili, Andrea Lapucci, Ida Landini, Marcella Coronnello, Giandomenico Roviello & Enrico Mini. (2020) Role of ATP-binding cassette transporters in cancer initiation and progression. Seminars in Cancer Biology 60, pages 72-95.
Crossref
Crossref
Pavan Kumar Cherukuri, Preeyaporn Songkiatisak, Feng Ding, Jean-Michel Jault & Xiao-Hong Nancy Xu. (2020)
Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of
Bacillus subtilis
. ACS Omega 5:3, pages 1625-1633.
Crossref
Crossref
Hao-Ran Sun, Shun Wang, Shi-Can Yan, Yu Zhang, Peter J. Nelson, Hu-Liang Jia, Lun-Xiu Qin & Qiong-Zhu Dong. (2019) Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment. Frontiers in Oncology 9.
Crossref
Crossref
Sangita Sridharan, Cory M. Howard, Augustus M. C. Tilley, Boopathi Subramaniyan, Amit K. Tiwari, Randall J. Ruch & Dayanidhi Raman. (2019) Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance. Frontiers in Oncology 9.
Crossref
Crossref
Vasilij Koshkin, Sven Kochmann, Apinaya Sorupanathan, Chun Peng, Laurie E. Ailles, Geoffrey Liu & Sergey N. Krylov. (2019) Cytometry of Reaction Rate Constant: Measuring Reaction Rate Constant in Individual Cells To Facilitate Robust and Accurate Analysis of Cell-Population Heterogeneity. Analytical Chemistry 91:6, pages 4186-4194.
Crossref
Crossref
Marcin Luty, Katarzyna Piwowarczyk, Anna Łabędź-Masłowska, Tomasz Wróbel, Małgorzata Szczygieł, Jessica Catapano, Grażyna Drabik, Damian Ryszawy, Sylwia Kędracka-Krok, Zbigniew Madeja, Maciej Siedlar, Martyna Elas & Jarosław Czyż. (2019) Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel. Cancers 11:1, pages 77.
Crossref
Crossref
Mukesh Verma & Vineet Kumar. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies
259
289
.
Iva Guberović, Marko Marjanović, Marija Mioč, Katja Ester, Irena Martin-Kleiner, Tatjana Šumanovac Ramljak, Kata Mlinarić-Majerski & Marijeta Kralj. (2018) Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells. Scientific Reports 8:1.
Crossref
Crossref
Gong Zhang, Shuping Zhang, Jinjin Ren, Chunxiao Yao, Zhongren Zhao, Xiurong Qi, Xiaofeng Zhang, Shuye Wang & Lei Li. (2018) Salinomycin may inhibit the cancer stem‑like populations with increased chemoradioresistance that nasopharyngeal cancer tumorspheres contain. Oncology Letters.
Crossref
Crossref
Jennifer Haynes, Trevor D. McKee, Andrew Haller, Yadong Wang, Cherry Leung, Deena M.A. Gendoo, Evelyne Lima-Fernandes, Antonija Kreso, Robin Wolman, Eva Szentgyorgyi, Douglass C. Vines, Benjamin Haibe-Kains, Bradly G. Wouters, Ur Metser, David A. Jaffray, Myles Smith & Catherine A. O'Brien. (2018) Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer. Clinical Cancer Research 24:9, pages 2116-2127.
Crossref
Crossref
Christina Schwarzenböck, Peter J. Nelson, Ralf Huss & Bernhard Rieger. (2018) Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery. Nanoscale 10:34, pages 16062-16068.
Crossref
Crossref
Lauren M. Browning, Kerry J. Lee, Pavan K. Cherukuri, Tao Huang, Preeyaporn Songkiatisak, Seth Warren & Xiao-Hong Nancy Xu. (2018)
Single gold nanoparticle plasmonic spectroscopy for study of chemical-dependent efflux function of single ABC transporters of single live
Bacillus subtilis
cells
. The Analyst 143:7, pages 1599-1608.
Crossref
Crossref
Santanu Maji, Sanjay Panda, Sabindra K. Samal, Omprakash Shriwas, Rachna Rath, Maurizio Pellecchia, Luni Emdad, Swadesh K. Das, Paul B. Fisher & Rupesh Dash. 2018.
37
75
.
Elle Koren & Yaron Fuchs. (2016) The bad seed: Cancer stem cells in tumor development and resistance. Drug Resistance Updates 28, pages 1-12.
Crossref
Crossref